Recent reports state that Manipal Hospitals is gearing up for what could become India’s largest healthcare listing, with the Temasek-backed hospital chain filing its draft red herring prospectus with the Securities and Exchange Board of India for an initial public offering estimated at over $1 billion. Led by Dr. Ranjan Pai, the company is reportedly targeting a valuation of around $13 billion, as it looks to strengthen its balance sheet through a mix of fresh capital and promoter stake dilution.
The proposed issue — comprising a ₹8,000 crore fresh raise alongside an offer for sale — comes at a time when Manipal Hospitals has established one of the most extensive footprints in India’s private healthcare sector, spanning dozens of hospitals and thousands of beds across the country. As the company prepares to enter public markets, here’s a look at their journey from a teaching hospital, to one of India’s largest healthcare companies.
From classrooms to pan-India hospital chain
The origin story of Manipal Hospitals dates back to 1953, when Dr. TMA Pai established Kasturba Medical College in Manipal, one of India’s earliest private medical institutes. The hospital business itself took shape in 1991, when TMA Pai’s son, Dr. Ramdas Pai established Manipal Hospitals. This integrated model of medical education and healthcare delivery would go on to become an advantage for the group, as it helped create a steady pipeline of trained medical professionals for their system.
Transformation under Dr. Rajan Pai
The 2000s saw further transformation of the group under the next generation, led by Dr. Ranjan Pai. In 2000, Dr. Ranjan Pai created the Manipal Education & Medical Group (MEMG) as a formal holding structure for healthcare and education businesses. The consolidation of the group’s businesses brought a more formal and scalable corporate structure and this phase saw the gradual professionalisation of operations, with increased focus on governance, expansion, and efficiency. In 2015, global private equity firm TPG invested in the company, marking the beginning of institutional ownership and expansion capital. This helped Manipal move from being a largely family-led enterprise to a professionally managed healthcare chain with a growing national presence.
Temasek inflection, expansion strategy, and milestones
Between 2016 and 2022, Manipal Hospitals entered an aggressive expansion phase, positioning itself as a consolidator in India’s fragmented healthcare market. In 2023, Singapore’s sovereign investment firm Temasek acquired a majority stake in Manipal Health Enterprises. The deal, which valued the company at roughly $5 billion, was among the largest healthcare transactions in India. It also marked a shift toward a more institutionally controlled ownership structure, with existing investors such as NIIF and TPG partially exiting, while Ranjan Pai retained a significant stake.
Post-investment, Manipal accelerated its growth and also expanded into diagnostics through its arm, Manipal HealthMap, acquiring chains such as MedCis PathLabs and iGenetic Diagnostics to build an integrated, pan-India testing network.
- 2016: Manipal Hospitals Whitefield opens (Bengaluru)
- 2018: Launch of Manipal Hospitals Dwarka
- 2021: Acquires Columbia Asia India hospitals and Vikram Hospital (Bengaluru)
- 2023: Acquisition of AMRI Hospitals and diagnostics services firm MedCis Pathlabs
- 2024: Acquires Medica Synergie and iGenetic Diagnostics
- 2025: Acquires Sahyadri Hospitals
Their strategy was clear: acquire existing hospital networks, rebrand under the Manipal umbrella, integrate operations, focus on high-end healthcare, and improve occupancy and margins. This playbook helped them scale rapidly and enter multiple specialties, while maintaining operational control. Plus, with institutional investors like Temasek and global private equity funds, Manipal had strong and steady access to capital. By the mid-2020s, Manipal had become one of India’s largest hospital networks in terms of beds and geographic footprint.
The business as it stands today
Today, Manipal Hospitals operates one of the largest healthcare platforms in India.
- 49 hospitals
- 24 cities
- 60+ specialties
- 12,600 beds
- 11,000 doctors
Manipal provides a comprehensive, integrated healthcare ecosystem, from outpatient consultations and diagnostics to advanced clinical treatments, while also extending care beyond hospitals through personalised home-care services. The company’s scale, combined with its focus on high-acuity care, positions it as one of the top hospital chains in the country (alongside companies like Fortis and Narayana Hrudalaya) in both size and capability. Manipal particularly stands out for its wide geographic footprint, integration with a medical education ecosystem, and its M&A-led scaling model.
What next?
The planned IPO marks the beginning of the next phase of growth. As reported, the IPO proceeds are expected to be used mainly to repay debt (following years of acquisition-led expansion), as well as to fund future growth and provide partial exits to existing investors. As the company prepares to enter the public markets, it does so not merely as a hospital operator, but as a consolidated, institutionally-backed healthcare platform, with an impressive and inspiring journey from a single medical college in Karnataka to a nationwide hospital network.
Sources
About Manipal Hospitals, India
We see Temasek as long-term partner: Pai – Times of India
Manipal HealthMap acquires iGenetic Diagnostics – The Economic Times
Diagnostic services firm Manipal HealthMap acquires MedCis PathLabs
Manipal Hospitals acquires 87% stake in hospital chain Medica Synergie
Temasek-backed Manipal Health files for $1.2 billion India IPO